Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA7 | P43166 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.41 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7419600 | 0.87 | MAPK1 (0.56) | MAPK1KDM4EL3MBTL1MAPTALDH1A1 | |
| SCHEMBL30460282 | 0.85 | MAPK1 (0.44) | MAPK1KDM4EL3MBTL1MAPTALDH1A1 | |
| SCHEMBL19876837 | 0.85 | MAPK1 (0.57) | MAPK1KDM4EL3MBTL1MAPTALDH1A1 | |
| SCHEMBL204895 | 0.84 | MAPK1 (0.61) | MAPK1KDM4EL3MBTL1MAPTALDH1A1 | |
| SCHEMBL29695095 | 0.84 | MAPK1 (0.61) | MAPK1KDM4EL3MBTL1MAPTALDH1A1 | |
| SCHEMBL1441132 | 0.84 | MAPK1 (0.61) | MAPK1KDM4EL3MBTL1MAPTALDH1A1 | |
| SCHEMBL1287501 | 0.83 | CA12 (0.50) | L3MBTL1MAPTALDH1A1CA1CA2 | |
| SCHEMBL1439028 | 0.83 | MAPK1 (0.59) | MAPK1KDM4EL3MBTL1MAPTALDH1A1 | |
| SCHEMBL17298235 | 0.83 | MAPK1 (0.59) | MAPK1KDM4EL3MBTL1MAPTALDH1A1 | |
| SCHEMBL198840 | 0.83 | MAPK1 (0.59) | MAPK1KDM4EL3MBTL1MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 472 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119823019-A | Indole compound with effect of treating idiopathic pulmonary fibrosis as well as preparation method and application thereof | 沈阳药科大学 | 2025-04-15 | — | — | CN | claimed |
| CN-113135907-A | Compound for improving alpha-tubulin acetylation level and preparation method and application thereof | 山东大学 | 2021-07-20 | — | — | CN | claimed |
| CN-107805241-B | Imidacloprid hapten, complete antigen, preparation method and application | 福建安欣睿捷生物科技有限公司 | 2020-05-26 | — | — | CN | claimed |
| CN-109020921-A | A kind of histon deacetylase (HDAC) HDAC6 inhibitor and the preparation method and application thereof | 山东大学 | 2018-12-18 | — | — | CN | claimed |
| CN-107805241-A | A kind of imidacloprid haptens, comlete antigen and preparation method and application | 福建安欣睿捷生物科技有限公司 | 2018-03-16 | — | — | CN | claimed |
| US-20260132111-A1 | Host-Targeted Pan-Respiratory Antiviral Small Molecule Therapeutics | PROSETTA BIOSCIENCES INC (US) | 2026-05-14 | — | — | US | disclosed |
| US-12590062-B2 | PD-1/PD-L1 inhibitors | GILEAD SCIENCES, INC. (US) | 2026-03-31 | — | — | US | disclosed |
| EP-4680602-A1 | HETEROCYCLIC COMPOUNDS AS SELECTIVE HDAC6 INHIBITORS | Miralinc Pharma, Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| EP-3976604-B1 | 1,3,4-OXADIAZOLE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | CHONG KUN DANG PHARMACEUTICAL CORP (KR) | 2026-01-21 | — | — | EP | disclosed |
| EP-4673444-A1 | OXADIAZOLE DERIVATIVE COMPOUNDS, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | Chong Kun Dang Pharmaceutical Corp. (KR) | 2026-01-07 | — | — | EP | disclosed |
| EP-4642461-A1 | COMPOSITIONS FOR PREVENTING AND TREATING RENAL FAILURE (RF) | Chong Kun Dang Pharmaceutical Corp. (KR) | 2025-11-05 | — | — | EP | disclosed |
| US-12459901-B2 | Host-targeted pan-respiratory antiviral small molecule therapeutics | PROSETTA BIOSCIENCES, INC. (US) | 2025-11-04 | — | — | US | disclosed |
| WO-1999012933-A2 | PYRROLOPYRROLONE DERIVATIVES AS INHIBITORS OF NEUTROPHIL ELASTASE | GLAXO GROUP LIMITED (GB) | 1999-03-18 | — | — | WO | disclosed |
| EP-0778821-A1 | ORTHO-SUBSTITUTED AROMATIC ETHER COMPOUNDS AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR PAIN RELIEF | ZENECA LIMITED (GB) | 1997-06-18 | — | — | EP | disclosed |
| WO-1996006822-A1 | ORTHO-SUBSTITUTED AROMATIC ETHER COMPOUNDS AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR PAIN RELIEF | ZENECA LIMITED (GB) | 1996-03-07 | — | — | WO | disclosed |
| US-5447949-A | Vision defects or cardiovascular disorders | SMITHKLINE BEECHAM CORPORATION (US) | 1995-09-05 | — | — | US | disclosed |
| EP-0585383-A4 | CHEMICAL COMPOUNDS | SMITHKLINE BEECHAM CORP (US) | 1994-08-17 | — | — | EP | disclosed |
| US-5317101-A | Antihyperalgesics | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1994-05-31 | — | — | US | disclosed |
| EP-0585383-A1 | CHEMICAL COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 1994-03-09 | — | — | EP | disclosed |
| WO-1992020651-A2 | N-(HETEROARYL)-IMIDAZOLYL-ALKENOIC ACIDS | SMITHKLINE BEECHAM CORPORATION (US) | 1992-11-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132111-A1 | Host-Targeted Pan-Respiratory Antiviral Small Molecule Therapeutics | NCOR1, HAVCR2, NR3C1 | MAPK1 3571/4885KDM4E 4577/4885L3MBTL1 2268/4885 |
| US-12590062-B2 | PD-1/PD-L1 inhibitors | CD274, PDCD1LG2, PDCD1 | MAPK1 1183/4885KDM4E 1970/4885L3MBTL1 1047/4885 |
| US-12459901-B2 | Host-targeted pan-respiratory antiviral small molecule therapeutics | MAVS, SARS1, ZC3HAV1 | MAPK1 4224/4885KDM4E 4045/4885L3MBTL1 2346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.